(Q43716886)

26 November 2017

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors (English)

1 reference

26 November 2017

Snyder RO

1

1 reference

26 November 2017

Miao CH

2

1 reference

26 November 2017

Patijn GA

3

1 reference

26 November 2017

Spratt SK

4

1 reference

26 November 2017

Danos O

5

1 reference

26 November 2017

Nagy D

6

1 reference

26 November 2017

Gown AM

7

1 reference

26 November 2017

Winther B

8

1 reference

26 November 2017

Meuse L

9

1 reference

26 November 2017

Cohen LK

10

1 reference

26 November 2017

Thompson AR

11

1 reference

26 November 2017

Kay MA

12

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

26 November 2017

1 reference

26 November 2017

16

1 reference

26 November 2017

270-276

1 reference

26 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/ng0797-270

26 November 2017

0 references

cites work

Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

Gene therapy for metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

In vivo model of adeno-associated virus vector persistence and rescue

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Adeno-associated virus general transduction vectors: analysis of proviral structures

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

An alternative approach to somatic cell gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1038%2FNG0797-270

7 January 2021

Identifiers

DOI

10.1038/NG0797-270

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference